Health
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become a best-in-class treatment for obesity. The Danish drugmaker is racing to capitalize on the runaway success of its blockbuster weight loss drug Wegovy by developing a new generation of treatments for obesity, including more convenient and […]
Read More
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty […]
Read More
Oura to sell its smart rings on Amazon as Apple, Samsung wearables competition grows
A closeup of Oura’s Gen3 Horizon ring and its sensors. Oura Oura will now sell its smart rings on Amazon, its latest retail expansion as the health and wellness wearable space continues to grow. Starting Thursday, Oura will have its full selection of rings and accessories available to U.S. shoppers on Amazon through its own […]
Read More
Cigna launches effort to cap employer insurance plan spending on weight loss drugs
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Cigna on Thursday unveiled a new effort to expand insurance coverage for weight loss drugs by limiting how much health plans and employers spend on the highly popular treatments each year. […]
Read More
Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20
US President Joe Biden speaks during an event at the National Institutes of Health (NIH) in Bethesda, Maryland, US, on Thursday, Dec. 14 2023. Chris Kleponis | Bloomberg | Getty Images President Joe Biden on Wednesday said the federal Medicare program should negotiate prices for at least 50 prescription drugs each year, up from the […]
Read More
Healthy Returns: What to know about CDC’s new Covid recommendations
A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia. Tami Chappell | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The Centers for Disease Control and Prevention announced two major new Covid recommendations last week. The […]
Read More
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
This picture taken on October 23, 2023, shows Ozempic medication boxes, an injectable antidiabetic drug, in a pharmacy in Riedisheim, eastern France. Sebastien Bozon | Afp | Getty Images Novo Nordisk‘s blockbuster drug Ozempic cut the risk of kidney disease progression and related health complications in diabetic patients, according to initial late-stage trial results released […]
Read More
We're in a 'boomer renaissance,' top hedge fund manager says — naming sectors and stocks to play it
Top hedge fund manager David Neuhauser says the world is in a “boomer renaissance” and investors should be betting big on certain sectors that play the theme. The world is aging rapidly, and sectors such as tourism, health care and biotech will benefit from that, according to Neuhauser, who is founder and chief investment officer […]
Read More
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target — in the budding weight loss drug market. Viking is just one of several companies racing to join the growing space. Some analysts say the market could be worth $100 billion by the end […]
Read More
Venture capital firm's plan to buy nonprofit hospital system has Ohio community on edge
Dr. Marc Harrison, who’s now CEO of HATCo, speaking at the Healthy Returns conference in New York City on May 21, 2019. Astrid Stawiarz | CNBC Dr. Marc Harrison is a different kind of venture capitalist. He’s not looking for the next Mark Zuckerberg or Elon Musk. He’s not hanging out at startup demo days. […]
Read More